University of Utah Technology Commercialization Office
Coming Soon! University of Utah Technology Commercialization Office
Innovations (235):
- Method and Composition of Stable Echogenic Nanoemulsions for Ultrasound-Mediated Chemotherapy and Ultrasound and MR Imaging of Solid Tumors (09 FEB 10)
- Surface Modified Nanoporous Substrate for High Sensitivity and High Density Microspot (06 FEB 10)
- U-4554 Selective Expansion of Regulatory T Cells for Therapeutic Applications (19 DEC 09)
- Novel Anti-Reductive Strategies for the Treatment of Heart Failure, Diabetes Mellitus and Degenerative Diseases (15 DEC 09)
- A Mouse Model of Synovial Sarcoma (15 DEC 09)
- Metal-based Membranes with Reduced Autofluorescence to Improve Detection and Imaging of Surface Analytes (15 DEC 09)
- Drug Delivery System That Targets Bone and Boosts Availability and Solubility of Therapeutic Drugs (15 DEC 09)
- Steroid-Targeted Therapeutics for the Treatment of Cancer (15 DEC 09)
- Alkylated HA and Derivatives (15 DEC 09)
- SCN9A is Mutated in Familial and Sporadic Febrile Convulsions (15 DEC 09)
Find more innovations
